Aemetis, Inc. (NASDAQ:AMTX) Short Interest Up 20.3% in August

Aemetis, Inc. (NASDAQ:AMTX) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 4,690,000 shares, a growth of 20.3% from the August 15th total of 3,900,000 shares. Based on an average daily volume of 734,700 shares, the days-to-cover ratio is currently 6.4 days.

Insider Activity

In other Aemetis news, Director Naomi Louise Boness sold 15,000 shares of the business’s stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $5.65, for a total value of $84,750.00. Following the completion of the transaction, the director now directly owns 16,441 shares in the company, valued at $92,891.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 14.34% of the company’s stock.

Institutional Trading of Aemetis

Hedge funds and other institutional investors have recently modified their holdings of the stock. Point72 Asset Management L.P. acquired a new stake in shares of Aemetis in the 2nd quarter worth $25,000. SG Americas Securities LLC purchased a new position in shares of Aemetis during the 1st quarter worth $31,000. Barclays PLC grew its holdings in shares of Aemetis by 542.0% during the 4th quarter. Barclays PLC now owns 8,031 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 6,780 shares during the period. Tower Research Capital LLC TRC grew its holdings in shares of Aemetis by 173.7% during the 3rd quarter. Tower Research Capital LLC TRC now owns 5,586 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 3,545 shares during the period. Finally, Deutsche Bank AG grew its holdings in shares of Aemetis by 66.9% during the 1st quarter. Deutsche Bank AG now owns 18,454 shares of the specialty chemicals company’s stock worth $43,000 after purchasing an additional 7,395 shares during the period. 27.95% of the stock is owned by institutional investors and hedge funds.

Aemetis Stock Performance

NASDAQ AMTX opened at $5.04 on Friday. The business has a fifty day moving average price of $6.34 and a 200 day moving average price of $4.67. Aemetis has a one year low of $1.16 and a one year high of $8.99. The company has a market cap of $195.80 million, a P/E ratio of -1.24 and a beta of 1.38.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Thursday, August 3rd. The specialty chemicals company reported ($0.68) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.40). The business had revenue of $45.11 million during the quarter, compared to analyst estimates of $67.30 million. As a group, sell-side analysts predict that Aemetis will post -1.79 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. HC Wainwright restated a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a research report on Friday. Stifel Nicolaus upped their price objective on Aemetis from $9.00 to $10.50 and gave the stock a “buy” rating in a research report on Tuesday, August 22nd. Piper Sandler upped their price objective on Aemetis from $2.00 to $3.00 in a research report on Tuesday, June 6th. Finally, UBS Group raised Aemetis from a “neutral” rating to a “buy” rating and upped their target price for the stock from $2.50 to $10.50 in a research note on Wednesday, August 16th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $13.42.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.